Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
headphones
CEimpact Podcast

CEimpact Podcast

CEimpact

The CEimpact Podcast features two shows - GameChangers and Precept2Practice!
The GameChangers Clinical Conversations podcast, hosted by Josh Kinsey, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Pharmacist By DesignTM subscribers can earn CE credit for each episode.
The Precept2Practice podcast, hosted by Kathy Scott, features information and resources for preceptors of students and residents. New episodes arrive on the third Wednesday of every month. Preceptor By DesignTM subscribers can earn CE credit for each episode.
To support our shows, give us a follow and check back each week for our latest episodes.

profile image

1 Listener

Share icon

All episodes

Best episodes

Seasons

Top 10 CEimpact Podcast Episodes

Goodpods has curated a list of the 10 best CEimpact Podcast episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to CEimpact Podcast for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite CEimpact Podcast episode by adding your comments to the episode page.

CEimpact Podcast - Socratic Questioning

Socratic Questioning

CEimpact Podcast

play

11/17/21 • 27 min

Repost Episode: Teaching is hard. Learn the what, why, and how of the Socratic Method and how using this process may aid preceptors in understanding what a student truly knows - and where more focus needs to be placed. Help your students think better with Socratic questioning!
Click here to download the Socratic Questioning handout!
Pearl 1: Describe the Socratic Method
Pearl 2: Identify reasons the Socratic Method is a useful precepting tool
Pearl 3: Implement the Socratic Method while precepting students
Guests:
Tracy Pettinger, PharmD
Clinical Associate Professor
Idaho State University
Lindsay Davis, PharmD, BCPS, BCCP, ASH-CHC, TTS
Professor
Midwestern University
Want more education on this topic? Visit these courses at www.CEimpact.com:
Learn to Teach in Practice: A Curriculum for the Clinician Educator
Do you want to advance your role as an educator in your practice setting?
Learn to Teach in Practice provides a pathway to explore, describe, apply, analyze and reflect on the role of the pharmacist as an educator in the pharmacy profession.
The Eleven Habits of Highly Effective Preceptors
Why is self-assessment important for preceptors, and how does it improve teaching? The Habits of Preceptors Rubric was designed to provide a robust assessment of an individual preceptor's habits. This course offers an introduction to this rubric as well as guidance on completing a self-assessment exercise which will create an actionable, impactful plan for continuous preceptor development.
Become a member today with our CEimpact Membership!

Follow CEimpact on Social Media:
LinkedIn
Instagram

profile image

1 Listener

bookmark
plus icon
share episode
CEimpact Podcast - A New Fungus Among Us

A New Fungus Among Us

CEimpact Podcast

play

02/26/24 • 24 min

Several outbreaks of a relatively new, resistant fungal infection - candida auris - have been reported in the Pacific Northwest. It is highly contagious and its mortality has approached 60%. Listen in as we discuss what to watch for and how to prepare if this reaches your geography.

THE GAMECHANGER:
Candida auris is resistant to most antifungals, has high plasticity, and its mortality approaches 60%.

Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
Cristina ML, Spagnolo AM, Sartini M, Carbone A, Oliva M, Schinca E, Boni S, Pontali E. An Overview on Candida auris in Healthcare Settings. J Fungi (Basel). 2023 Sep 8;9(9):913. doi: 10.3390/jof9090913. PMID: 37755021; PMCID: PMC10532978.
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss characteristics of C. auris infections that make it difficult to avoid outbreaks 2. Describe issues surrounding treatment of serious infections with C. auris
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-058-H01-P
Initial release date: 2/26/2024
Expiration date: 2/26/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

bookmark
plus icon
share episode
CEimpact Podcast - A Trippy Trial of Psilocybin for Depression
play

08/10/21 • 35 min

Do psychedelics treat mental illness? In this GameChanger episode host, Geoff Wall and guest, Sarah Grady, a psychiatric pharmacist, discuss a recent NEJM article comparing psilocybin (magic mushrooms) to escitalopram.
Guest:
Sarah Grady, PharmD
Drake University
Redeem your CPE or CME credit here with your GameChangers Subscription!
We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964
References and resources:
Carhart-Harris R, Giribaldi B, Watts R, et al. Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med. 2021 Apr 15;384(15):1402-1411. doi: 10.1056/NEJMoa2032994. PMID: 33852780.
Continuing Education Information:
Learning Objectives:
1. Discuss a recent study comparing psilocybin to escitalopram in depression
2. Identify potential patients that could benefit from psilocybin based on the study
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-231-H01-P
Initial release date: 8/3/21
Expiration date: 8/3/22
Dr. Sarah Grady reports no actual or potential conflicts of interest associated with this activity.
Complete CPE & CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

bookmark
plus icon
share episode
CEimpact Podcast - Do Masks Work or Not?

Do Masks Work or Not?

CEimpact Podcast

play

03/27/23 • 29 min

Although the numbers may be low, COVID-19 and other illnesses remain a significant threat to patients. The role of masks in preventing SARS-CoV-2 spread has been politicized since the beginning. A new meta-analysis purports to answer the question of mask effectiveness. Join host Geoff Wall, with guest Jake Galdo, as they deep dive into the article and evaluate the science.
The GameChanger
A new meta-analysis suggests that mask mandates do not affect the prevention and spread of COVID-19. However, the study has numerous limitations and errors, making its interpretation difficult.
Show Segments
00:00 - Introductions
01:31 - Pros and Cons of a Meta-Analysis
06:31: Looking at the Analysis
10:24 - The GameChanger: Jefferson et al. Results
11:24 - Connecting to Practice: Recognizing Limitations
28:43 - Closing Remarks
Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad
References and Resources
Jefferson T, Dooley L, Ferroni E, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses (Review). Cochrane Library.
Novella S. Masks Revisited. Science Based Medicine.
Redeem your CPE here
CPE (Pharmacist)
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership
CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the pros and cons of a meta-analysis
2. Describe the limitations of the Jefferson et al meta-analysis
0.05 CEU/0.5 Hr
UAN: 0107-0000-23-119-H01-P
Initial release date: 03/22/2023
Expiration date: 03/22/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

bookmark
plus icon
share episode
CEimpact Podcast - The COVID-19 Reality: An Update
play

10/03/22 • 29 min

Get FREE CE for this episode by downloading the CEimpact App (details in the FREE CE section).

The current reality of COVID-19 is reviewed in this episode by Dr. Katelyn Jetelina. Dr. Jetelina is an epidemiologist and author of the wildly popular Newsletter, Your Local Epidemiologist, available via Substack.

We are losing ~400 Americans a day. During the first week of September, we lost 2,299 people. In August 2022 alone, we lost 15,284 Americans to COVID-19. This means COVID-19 remains the third leading cause of death in our repertoire of threats. And it’s largely preventable[1].

Pharmacists continue to support the frontlines of the COVID-19 Pandemic. This episode shares insights on the current reality as well as what you need to know about bivalent boosters, and vaccinating children.

The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training. Use discount code THANKYOU to save 10%.
Show Segments

00:00 - Introductions

03:38 - Is COVID-19 Still a Thing?

10:55 - The GameChanger: Bivalent Booster

17:15 - The Different Boosters

19:40 - Applying to Practice: Dosing

22:48 - Pediatric Considerations

28:35 - Closing Thoughts

References and Resources

  1. 400 Americans are dying each day. We cannot accept this reality.
  2. Virtual Immunization Administration Training
  3. Get the CEimpact App

Host
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc
Guest
Katelyn Jetelina, MPH, PhD
Publisher, Your Local Epidemiologist

Subscribe to Katelyn's substack - Your Local Epidemiologist to receive a direct line of “translated” public health science to the local, national, and international community.
Redeem your CPE or CME here

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)


CE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the current state of COVID-19 pandemic the United States
2. Describe the role of a bivalent vaccine for COVID-19
0.05 CEU/0.5 Hr
UAN: 0107-0000-22-370-H-06-P
Initial release date: 10/3/2022
Expiration date: 10/3/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

bookmark
plus icon
share episode
CEimpact Podcast - Who Gets an Additional Dose of COVID-19 Vaccines?
play

08/24/21 • 29 min

The Delta variant has made it clear the COVID pandemic is far from over. Recent studies have suggested that immunocompromised patients may have a reduced or no antibody response to the currently available COVID-19 vaccines. On August 13th, the CDC and FDA recommended that patients receive an additional vaccination. Hear Dr. Geoff Wall and guest, Dr. Nicole Alvey, on how immunocompromised patients need an additional dose, and how to prioritize their care. Drs. Wall and Alvey also share preliminary thoughts on booster vaccines based on the U.S. Surgeon General’s announcement on 8.18.21 recommending booster shots available at 8 months; however, the Biden administration announced on 8.25.21 that booster shots should be available after 6 months of the last dose, pending ACIP review.
Guest:
Nicole Alvey, PharmD, BCPS, FAST
Associate Professor, Roosevelt University
Earn CME or CPE credit with a GameChangers Subscription!
Want more? Head over to The Pharmacy Network to watch our Expert in Residence discuss all things COVID-19 boosters + additional shots titled All About Boosters.
References and resources:
Continuing Education Information:
Learning Objectives:
1. Describe risk factors for having a poor antibody response to currently available COVID-19 vaccines
2. Implement new recommendations for an additional vaccination of COVID-19 in eligible patients
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-XXX-H06-P
Initial release date: 8/24/21
Expiration date: 9/7/22
Dr. Alvey reports no actual or potential conflicts of interest associated with this activity.
Complete CPE & CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

bookmark
plus icon
share episode
CEimpact Podcast - The Novel RSV Vaccine: Part 2
play

05/08/23 • 31 min

Respiratory syncytial virus (RSV) is a leading cause of pneumonia and hospitalizations in children and older adults. A search for a vaccine may finally be over. Join host, Geoff Wall, and guest, Jake Galdo, as they dive into part 2 of a two-part series examining new research on the proposed RSV vaccine.
The GameChanger
RSV, COVID-19, and influenza are major disease burdens on children and older adults. Fortunately, COVID-19 and influenza have widely available vaccines – and maybe soon for RSV. A recent study of the mRNA vaccine in pregnant patients may help newborns.
Show Segments
00:00 - Introductions
02:57 - Recap From Part 1
06:45 - Looking at the MATISSE Study
14:17 - The GameChanger: MATISSE Results
22:27 - Connecting to Practice: Barriers to Applying
31:05 - Closing Remarks
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP

Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Guest
Jake Galdo, PharmD, MBA, BCPS, BCGP

Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad
Reference
Kampmann B, Madhi SA, Munjal I, et al. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5. PMID: 37018474.
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CE Information
Learning Objectives

Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the MATISSE study in relation to RSV vaccines
2. Describe barriers to applying the information in this study to general populations
0.05 CEU/0.5 Hr
UAN: 0107-0000-23-193-H06-P
Initial release date: 05/08/2023
Expiration date: 05/08/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

bookmark
plus icon
share episode
CEimpact Podcast - Is the Price Right for Aducanumab?
play

07/27/21 • 37 min

The first new treatment for Alzheimer's, aducanumab, was approved by the Food and Drug Administration on June 7, 2021. This approval did not come without controversy. Learn what the available data show for efficacy and safety and whether or not the current list price of $56,000 per year meets cost-effectiveness thresholds.
Guest
John A Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad
Redeem your CPE or CME credit here!
We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964

References and resources:
Aducanumab for Alzheimer's Disease: Effectiveness and Value. Institute for Clinical and Economic Review. June 30, 2021. https://icer.org/wp-content/uploads/2020/10/ICER_ALZ_Revised_Evidence_Report_06302021.pdf
Continuing Education Information:
Learning Objectives:
1. Discuss the outcomes for phase III trials of aducanumab
2. Define the cost-effectiveness of aducanumab
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-265-H01-P
Initial release date: 7/27/21
Expiration date: 7/27/22
John A. Galdo reports that he is on a speaker's bureau for Novo Nordisk.
Complete CPE & CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

bookmark
plus icon
share episode
CEimpact Podcast - Does the Shingles Vaccine Delay Dementia?
play

08/19/24 • 21 min

Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay it's onset.
The GameChanger
Several studies suggest a delay in onset of dementia with the recombinant shingles vaccine.
Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
The recombinant shingles vaccine is associated with lower risk of dementia
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe dementia's epidemiology and the significance of preventive interventions.
2. Discuss the strengths, weaknesses, and outcomes of the study.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-246-H01-P
Initial release date: 08/19/2024
Expiration date: 08/19/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

bookmark
plus icon
share episode
CEimpact Podcast - Negotiating High-Cost Drugs
play

04/08/24 • 30 min

This episode discusses the 2023 Inflation Reduction Act and HHS's authority to negotiate prices for high-cost drugs in Medicare Part D. In addition to the initial list of 10 drugs, HHS is now focused on medications used in the hospital and covered under Medicare Part B.
The GameChanger
HHS updates the Inflation Reduction Act that will impact over 750, 000 people.
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad
Reference
Reduced Coinsurance for Certain Part B Rebatable Drugs Under the Medicare Prescription Drug Inflation Rebate Program

HHS Announces Savings for 41 Prescription Drugs Thanks to Inflation Rebates from the Biden-Harris Administration’s Lower Cost Prescription Drug Law

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the monetary impact of the Inflation Reduction Act.
2. Discuss how the Medicare Part B drug addition will benefit patients.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-136-H04-P
Initial release date: 4/08/2024
Expiration date: 04/08/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

bookmark
plus icon
share episode

Show more best episodes

Toggle view more icon

FAQ

How many episodes does CEimpact Podcast have?

CEimpact Podcast currently has 326 episodes available.

What topics does CEimpact Podcast cover?

The podcast is about Pharmacology, Pharmacy, Cme, Courses, Podcasts, Education and Science.

What is the most popular episode on CEimpact Podcast?

The episode title 'Socratic Questioning' is the most popular.

What is the average episode length on CEimpact Podcast?

The average episode length on CEimpact Podcast is 28 minutes.

How often are episodes of CEimpact Podcast released?

Episodes of CEimpact Podcast are typically released every 7 days.

When was the first episode of CEimpact Podcast?

The first episode of CEimpact Podcast was released on May 22, 2020.

Show more FAQ

Toggle view more icon

Comments